Baxter International Inc. (BAX) has a MoatMap StockRank of 51/100 based on Quality (41/100), Value (53/100), and Momentum (43/100) factor scores. The current signal is HOLD. Baxter is a medical technology company undergoing a complex restructuring and debt reduction phase. It lacks the high ROIC and clear organic growth runway of a high-conviction compounder.
Baxter International Inc. is a global healthcare company providing a broad portfolio of essential healthcare products, including kidney dialysis, sterile IV solutions, infusion systems, and surgical equipment. The company benefits from high switching costs for critical medical devices and a global installed base within hospitals and clinics. Baxter is a significant player in kidney care and hospital products, offering life-sustaining therapies and essential medical technologies worldwide.
| Price | $18.40 |
| Market Cap | $9.9B |
| P/E (Forward) | 9.64 |
| Price/Book | 1.66 |
| Return on Equity | -15.0% |
| Return on Invested Capital | -1.3% |
| Debt/Equity | 161.02 |
| Gross Margin | 34.6% |
| Operating Margin | 6.0% |
| Revenue Growth | 2.9% |
| Dividend Yield | 1.0% |
| Free Cash Flow | $901M |
Baxter International Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).